• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HEMOSPHERE, INC. HERO GRAFT; VASCULAR GRAFT PROSTHESIS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HEMOSPHERE, INC. HERO GRAFT; VASCULAR GRAFT PROSTHESIS Back to Search Results
Model Number HERO 1001
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Bacterial Infection (1735)
Event Type  Injury  
Event Description
According to a manuscript, the end stage of dialysis access: femoral graft or hero vascular access device, a patient developed bacteremia after hero graft implant.As bacteremia is a blood borne infection it is not know what component, if any, of the hero device contributed to the infection.This medwatch is for product code (b)(4).
 
Manufacturer Narrative
According to a manuscript, the end stage of dialysis access: femoral graft or hero vascular access device, a patient developed bacteremia after hero graft implant.As bactermia is a blood borne infection it is not know what component, if any, of the hero device contributed to the infection.This medwatch is for product code (b)(6).Product is terminally sterilized by a validated method and pcd's were found to be sterile post processing.The manufacturing records for lots, 0001742, 0001743, and 0001747 were reviewed, and it was confirmed that all records were controlled, available for review, and met all specifications per the device master record.Without information about the timing and source of the infection, the relationship of the infection to the hero graft device in dr.Wong's patient cannot be determined.Infection is a known potential complication listed in the hero graft instructions for use (ifu).The hero graft ifu contraindicates use of the hero device in patients with known preexisting bacteremia.In addition, instructions for screening blood cultures to rule out asymptomatic bacteremia and recommended antibiotic therapy are also provided in the ifu.There is no indication that an error or deficiency occurred at cryolife and the ifu adequately communicates risk.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HERO GRAFT
Type of Device
VASCULAR GRAFT PROSTHESIS
Manufacturer (Section D)
HEMOSPHERE, INC.
1655 roberts blvd. nw
kennesaw GA 30144
Manufacturer (Section G)
HEMOSPHERE, INC.
1655 roberts blvd. nw
kennesaw GA 30144
Manufacturer Contact
sandra o'reilly
1655 roberts blvd., nw
kennesaw, GA 30144
7704193355
MDR Report Key4322264
MDR Text Key17265668
Report Number3006945290-2014-00104
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 06/19/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/11/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model NumberHERO 1001
Device Lot Number0001747
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/19/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-